Currently out of the existing stock ratings of Matthew Carletti, 314 are a BUY (92.63%), 25 are a HOLD (7.37%).

Matthew Carletti

Work Performance Price Targets & Ratings Chart

Analyst Matthew Carletti, carries an average stock price target met ratio of 59.9% that have a potential upside of 38.46% achieved within 390 days. Previously, Matthew Carletti worked at JMP.

Matthew Carletti’s has documented 643 price targets and ratings displayed on 35 stocks. The coverage was on Financial Services, Healthcare sectors.

Most recent stock forecast was given on BRO, Brown & Brown at 12-Oct-2026.

Wall Street Analyst Matthew Carletti

Analyst best performing recommendations are on LIFE (ATYR PHARMA).
The best stock recommendation documented was for PLMR (PALOMAR HOLDINGS) at 2/19/2020. The price target of $60 was fulfilled within 1 day with a profit of $2.58 (4.49%) receiving and performance score of 44.93.

Average potential price target upside

of $98.6 (15.9%) on Y (ALLEGHANY).
of $44.99 (23.01%) on CB (CHUBB LTD).
of $41.83 (85.9%) on GSHD (GOOSEHEAD INSURANCE).

ACGL Arch Capital Group Ltd AMSF AMERISAFE CB Chubb Ltd GSHD Goosehead Insurance HCI HCI Group HRTG Heritage Insurance Hldgs NGHC National General Holdings Corp PLMR Palomar Holdings PRA ProAssurance ROOT Root THG The Hanover Insurance Group TIG Trean Insurance Group WTRE WisdomTree New Economy Real Estate ETF DOMA Doma Holdings LMND Lemonade SIGI Selective Insurance Group KMPR Kemper MHLD Maiden Holdings Ltd Y Alleghany HIPO Hippo Holdings JRVR James River Group Holdings Ltd KNSL Kinsale Capital Group ORI Old Republic International Corp RYAN Ryan Specialty Group Holdings HMN Horace Mann Educators RLI RLI Corp BOW Bowhead Specialty Holdings FIHL Fidelis Insurance Holdings HG Hamilton Insurance Group, Ltd. SKWD Skyward Specialty Insurance Group CBC STC Stewart Information Services Corp ARX BRO Brown & Brown LIFE aTyr Pharma

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Pablo Singzon (JPMORGAN)

Hold Since 20-Jul-2026

$113

$11.31 (11.12%)

$118

13 days ago
(12-Oct-2026)

0/4 (0%)

$17.43 (18.24%)

Please subscribe to see extended stock data

Elyse Greenspan (WELLS FARGO)

Buy Since 01-Apr-2020

$107

$5.31 (5.22%)

$117

13 days ago
(12-Oct-2026)

24/39 (61.54%)

$11.43 (11.96%)

259

Please subscribe to see extended stock data

Meyer Shields (STIFEL)

Hold Since 07-Apr-2026

$95

$-6.69 (-6.58%)

$99

13 days ago
(12-Oct-2026)

17/23 (73.91%)

$-0.57 (-0.60%)

207

Please subscribe to see extended stock data

Ryan Tunis (CANTOR FITZGERALD)

Hold Since 10-Feb-2026

$105

$3.31 (3.25%)

$110

18 days ago
(07-Oct-2026)

4/6 (66.67%)

$10.67 (11.31%)

Please subscribe to see extended stock data

Bob Huang (MORGAN STANLEY)

Buy Since 27-Jul-2023

$105

$3.31 (3.25%)

$110

19 days ago
(06-Oct-2026)

5/10 (50%)

$10.18 (10.74%)

317

Please subscribe to see extended stock data

Show more analysts

Please expand the browser size to see the chart

Which stock is Matthew Carletti most bullish on?

Potential upside of $60.94 has been obtained for HCI (HCI GROUP)

Which stock is Matthew Carletti most reserved on?

Potential downside of -$3.1 has been obtained for LIFE (ATYR PHARMA)